Haris P Subacius
Overview
Explore the profile of Haris P Subacius including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
182
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatt A, Vaduganathan M, Patel R, Fonarow G, Subacius H, Konstam M, et al.
Eur J Heart Fail
. 2019 Dec;
22(1):164-167.
PMID: 31797490
No abstract available.
2.
Greene S, Fonarow G, Solomon S, Subacius H, Vaduganathan M, Ambrosy A, et al.
Eur J Heart Fail
. 2018 Nov;
20(12):1760-1763.
PMID: 30415473
No abstract available.
3.
Greene S, Butler J, Fonarow G, Subacius H, Ambrosy A, Vaduganathan M, et al.
Eur J Heart Fail
. 2017 Oct;
20(2):281-291.
PMID: 29044915
Aims: Troponin levels are commonly elevated among patients hospitalized for heart failure (HF), but the prevalence and prognostic significance of early post-discharge troponin elevation are unclear. This study sought to...
4.
Greene S, Fonarow G, Solomon S, Subacius H, Ambrosy A, Vaduganathan M, et al.
Eur J Heart Fail
. 2016 Oct;
19(4):552-562.
PMID: 27748006
Aims: Change in NT-proBNP level is a common surrogate endpoint in early phase heart failure (HF) trials, but whether this endpoint is influenced by atrial fibrillation/flutter (AFF) is unclear. Methods...
5.
Vaduganathan M, Marti C, Mentz R, Greene S, Ambrosy A, Subacius H, et al.
Am J Cardiol
. 2016 Feb;
117(7):1144-50.
PMID: 26851146
Serum osmolality may fluctuate with neurohormonal activation and in response to certain therapeutics in patients with heart failure (HF). The clinical relevance of osmolality in patients with HF has not...
6.
Vaduganathan M, Greene S, Ambrosy A, Mentz R, Subacius H, Chioncel O, et al.
Am J Cardiol
. 2014 Oct;
114(11):1713-21.
PMID: 25312638
We investigated the clinical profiles associated with serum uric acid (sUA) levels in a large cohort of patients hospitalized for worsening chronic heart failure with ejection fraction (EF) ≤40%, with...
7.
Vaduganathan M, Dei Cas A, Mentz R, Greene S, Khan S, Subacius H, et al.
Am J Cardiol
. 2014 Jul;
114(5):743-50.
PMID: 25060414
Despite the well-established benefits of mineralocorticoid receptor agonists (MRAs) in heart failure with reduced ejection fraction, safety concerns remain in patients with concomitant diabetes mellitus (DM) because of common renal...
8.
Mentz R, Greene S, Ambrosy A, Vaduganathan M, Subacius H, Swedberg K, et al.
Circ Heart Fail
. 2014 Apr;
7(3):401-8.
PMID: 24737459
Background: Anemia has been associated with worse outcomes in patients with chronic heart failure (HF). We aimed to characterize the clinical profile and postdischarge outcomes of hospitalized HF patients with...
9.
Vaduganathan M, Greene S, Ambrosy A, Mentz R, Fonarow G, Zannad F, et al.
Am J Cardiol
. 2013 Oct;
112(11):1763-9.
PMID: 24095030
Serum magnesium levels may be impacted by neurohormonal activation, renal function, and diuretics. The clinical profile and prognostic significance of serum magnesium level concentration in patients hospitalized for heart failure...
10.
Greene S, Vaduganathan M, Lupi L, Ambrosy A, Mentz R, Konstam M, et al.
Am J Cardiol
. 2012 Dec;
111(4):574-81.
PMID: 23206923
Lower cholesterol levels are associated with worse outcomes in patients with chronic heart failure (HF) and have been shown to predict in-hospital mortality. The relation between lipid profile and postdischarge...